Vasculitis are a heterogeneous group of disorders characterized by inflammation of the blood vessels of different caliber and sometimes fibrinoid necrosis with vessel wall destruction [1] .
Vasculitis are divided into cutaneous and systemic forms, primary and secondary to hypertension, immunosuppression therapy, metabolic complications. The classification is based on the affected vessel size ( Table 1) . They may have neurological manifestations at the onset and during the desease development. These are more common in systemic forms such as SLE and Nodose Polyarteritis (PAN).
The Schonlein-Henoch purpura and Kawasaki disease, the most frequent vasculitisin childhood, rarely can have neurological disorders. There are forms of mild to moderate intensity like headache, irritability, mood disorders and behavioral and forms of severe as seizures and sensory disturbance up to coma.
In the course of SLE, neuropsychiatric manifestations, headache and chorea are common, with an incidence of 20-40% (also 80% with cognitive disorders and asymptomatic alterations RMN). The neuropsychiatric manifestations involve 40-56% of children; headache the 22-64%; convulsions the 20-31%; chorea 4-10%; peripheral neuropathy 5-6%; myelopathy 1%. Heterogeneity in their neurological symptoms are important for prognostic purposes.
In antiphospholipid syndrome, primary or secondary, the following are common: transient cerebral ischemia and ischemic stroke, memory loss, chorea, seizures, vision problems [2] .
The PAN is a necrotizing vasculitis histo-pathological examination, rarely aneurysm, stenosis or occlusion (not caused by fibro-muscular dysplasia, or by other causes not inflammatory) artery of small and medium caliber. In addition, at least one of the following signs/symptoms: skin involvement (livedo, nodules or heart attacks); myalgia; hypertension; peripheral neuropathy (sensory or motor); renal involvement (proteinuria, haematuria, renal impairment).
The primary central nervous system vasculitis is a brain vessels inflammation not associated with vasculitis of other organs. The classification is based on the vessel size: small (with normal angiography) and medium-large (progressive and non-progressive). This form, responsible for 40-60% of arterial ischemic stroke, affects 3-8/ 100.000 children/year. Symptoms are characterized by acute severe headache (80%), focal neurological deficit (78%), motor deficit (62%), cognitive disorders (54%), cranial nerve involvement (59%), seizures (small vessel vasculitis). Peripheral neuropathies are characteristic of the Churg-Strauss disease.
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